Dear Millionaires, Market Update is a new playlist in our MMM channel introduced to cover the important data like previous day chart, results, top stocks, dividend and break out stocks for trading with ease.
Watch | Like | Subscribe
•Market Update Sensex closes 169 points higher at 40,795 & Nifty 37 points higher at 11,971 Nifty Bank gains 382 points
•Gold price today: Yellow metal gains; may face resistance at Rs 50,550 per 10 gm
•Silver futures traded 0.39 percent higher at Rs 60,781 per kg
•Wipro top Nifty loser as stock sees profit-booking after Q2 earnings
•Info Edge moves higher on company's comment of business being back to pre-COVID levels
• Praj Industries surges 5% on government's optimistic plan on ethanol
•PNB Gilts The stock jumped over 4 percent after CRISIL re-affirmed its credit rating of 'A1+' as assigned to Rs 1,000 crore Commercial Paper programme
NMDC The stock price was up a percent after the Cabinet approves demerger, sale of NMDC's Nagarnar steel plant, reported CNBC-TV18
•Karnataka Bank's share price traded 4 percent to Rs 43.75 per share on the NSE after company reported a nearly 13 percent rise in net profit at Rs 119.44 crore for the September quarter as bad loans moderated.
•Tata Power | The company will develop 100 MW Solar Project in Dholera, Gujarat.
•Infosys Q2 beats estimates with 14.4% profit growth;
•KIOCL freezes at 10% upper circuit as Board to mull share buyback
•Lupin The stock was down over a percent on October 14. Rakesh Jhunjhunwala increased stake in company to 1.53 percent in September quarter, from 1.47 percent in June quarter
•YES Bank The stock ended in the red after reports that it had classified Cox & Kings as wilful defaulters
•Infibeam Avenues The stock was up 3 percent after JPMorgan Chase Bank N.A., India (JPMC) has signed a definitive agreement with Infibeam Avenues, to use company's flagship enterprise payment platform, CCAvenue for processing transactions of its enterprise clients.
•Sun Pharma The stock added 2 percent after the company reported positive top-line results from its Phase 3 trial for its investigational drug, SDN-037, for the treatment of Inflammation and Pain associated with Ocular Surgery.
• Page Industries The share price ended in th red after A US apparel industry watchdog has launched an investigation into underwear maker Jockey International's Indian partner Page Industries following allegations of human rights abuses at one of its factories, Reuters reported